{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T14:16:10Z","timestamp":1778336170834,"version":"3.51.4"},"reference-count":38,"publisher":"Japan Atherosclerosis Society","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT"],"published-print":{"date-parts":[[2014]]},"DOI":"10.5551\/jat.20859","type":"journal-article","created":{"date-parts":[[2013,11,19]],"date-time":"2013-11-19T03:44:00Z","timestamp":1384832640000},"page":"17-22","source":"Crossref","is-referenced-by-count":26,"title":["MicroRNAs and Lipoprotein Metabolism"],"prefix":"10.5551","author":[{"given":"Takahiro","family":"Horie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Baba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhide","family":"Kuwabara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Yokode","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Kita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koh","family":"Ono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Bartel DP: Micrornas: Genomics, biogenesis, mechanism, and function. Cell, 2004; 116: 281-297","DOI":"10.1016\/S0092-8674(04)00045-5"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Ambros V: The functions of animal micrornas. Nature, 2004; 431: 350-355","DOI":"10.1038\/nature02871"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Lee RC, Feinbaum RL, Ambros V: The c. Elegans heterochronic gene lin-4 encodes small rnas with antisense complementarity to lin-14. Cell, 1993; 75: 843-854","DOI":"10.1016\/0092-8674(93)90529-Y"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Wightman B, Ha I, Ruvkun G: Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in c. Elegans. Cell, 1993; 75: 855-862","DOI":"10.1016\/0092-8674(93)90530-4"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Lewis BP, Burge CB, Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microrna targets. Cell, 2005; 120: 15-20","DOI":"10.1016\/j.cell.2004.12.035"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Friedman RC, Farh KK, Burge CB, Bartel DP: Most mammalian mrnas are conserved targets of micrornas. Genome Res, 2009; 19: 92-105","DOI":"10.1101\/gr.082701.108"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Kozomara A, Griffiths-Jones S: Mirbase: Integrating microrna annotation and deep-sequencing data. Nucleic Acids Res, 2011; 39: D152-157","DOI":"10.1093\/nar\/gkq1027"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Rottiers V, Naar AM: Micrornas in metabolism and metabolic disorders. Nat Rev Mol Cell Biol, 2012; 13: 239-250","DOI":"10.1038\/nrm3313"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Moore KJ, Rayner KJ, Suarez Y, Fernandez-Hernando C: Micrornas and cholesterol metabolism. Trends Endocrinol Metab, 2010; 21: 699-706","DOI":"10.1016\/j.tem.2010.08.008"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Norata GD, Sala F, Catapano AL, Fernandez-Hernando C: Micrornas and lipoproteins: A connection beyond atherosclerosis? Atherosclerosis, 2013; 227: 209-215","DOI":"10.1016\/j.atherosclerosis.2012.11.019"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, Stoffel M: Silencing of micrornas in vivo with \u2018antagomirs\u2019. Nature, 2005; 438: 685-689","DOI":"10.1038\/nature04303"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Esau C, Davis S, Murray SF, Yu XX, Pandey SK, Pear M, Watts L, Booten SL, Graham M, McKay R, Subramaniam A, Propp S, Lollo BA, Freier S, Bennett CF, Bhanot S, Monia BP: Mir-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab, 2006; 3: 87-98","DOI":"10.1016\/j.cmet.2006.01.005"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Elmen J, Lindow M, Schutz S, Lawrence M, Petri A, Obad S, Lindholm M, Hedtjarn M, Hansen HF, Berger U, Gullans S, Kearney P, Sarnow P, Straarup EM, Kauppinen S: Lna-mediated microrna silencing in non-human primates. Nature, 2008; 452: 896-899","DOI":"10.1038\/nature06783"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Wen J, Friedman JR: Mir-122 regulates hepatic lipid metabolism and tumor suppression. J Clin Invest, 2012; 122: 2773-2776","DOI":"10.1172\/JCI63966"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Hsu SH, Wang B, Kota J, Yu J, Costinean S, Kutay H, Yu L, Bai S, La Perle K, Chivukula RR, Mao H, Wei M, Clark KR, Mendell JR, Caligiuri MA, Jacob ST, Mendell JT, Ghoshal K: Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of mir-122 in liver. J Clin Invest, 2012; 122: 2871-2883","DOI":"10.1172\/JCI63539"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Rayner KJ, Suarez Y, Davalos A, Parathath S, Fitzgerald ML, Tamehiro N, Fisher EA, Moore KJ, Fernandez-Hernando C: Mir-33 contributes to the regulation of cholesterol homeostasis. Science, 2010; 328: 1570-1573","DOI":"10.1126\/science.1189862"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Najafi-Shoushtari SH, Kristo F, Li Y, Shioda T, Cohen DE, Gerszten RE, Naar AM: Microrna-33 and the srebp host genes cooperate to control cholesterol homeostasis. Science, 2010; 328: 1566-1569","DOI":"10.1126\/science.1189123"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Marquart TJ, Allen RM, Ory DS, Baldan A: Mir-33 links srebp-2 induction to repression of sterol transporters. Proc Natl Acad Sci U S A, 2010; 107: 12228-12232","DOI":"10.1073\/pnas.1005191107"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Horie T, Ono K, Horiguchi M, Nishi H, Nakamura T, Nagao K, Kinoshita M, Kuwabara Y, Marusawa H, Iwanaga Y, Hasegawa K, Yokode M, Kimura T, Kita T: Microrna-33 encoded by an intron of sterol regulatory element-binding protein 2(srebp2) regulates hdl in vivo. Proc Natl Acad Sci U S A, 2010; 107: 17321-17326","DOI":"10.1073\/pnas.1008499107"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Gerin I, Clerbaux LA, Haumont O, Lanthier N, Das AK, Burant CF, Leclercq IA, MacDougald OA, Bommer GT: Expression of mir-33 from an srebp2 intron inhibits cholesterol export and fatty acid oxidation. J Biol Chem, 2010; 285: 33652-33661","DOI":"10.1074\/jbc.M110.152090"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Brown MS, Ye J, Goldstein JL: Medicine. Hdl mir-ed down by srebp introns. Science, 2010; 328: 1495-1496","DOI":"10.1126\/science.1192409"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Brown MS, Goldstein JL: The srebp pathway: Regulation of cholesterol metabolism by proteolysis of a membranebound transcription factor. Cell, 1997; 89: 331-340","DOI":"10.1016\/S0092-8674(00)80213-5"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Horton JD, Shimomura I: Sterol regulatory elementbinding proteins: Activators of cholesterol and fatty acid biosynthesis. Curr Opin Lipidol, 1999; 10: 143-150","DOI":"10.1097\/00041433-199904000-00008"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Horton JD, Goldstein JL, Brown MS: Srebps: Activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest, 2002; 109: 1125-1131","DOI":"10.1172\/JCI0215593"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Allen RM, Marquart TJ, Albert CJ, Suchy FJ, Wang DQ, Ananthanarayanan M, Ford DA, Baldan A: Mir-33 controls the expression of biliary transporters, and mediates statin- and diet-induced hepatotoxicity. EMBO Mol Med, 2012; 4: 882-895","DOI":"10.1002\/emmm.201201228"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Rayner KJ, Sheedy FJ, Esau CC, Hussain FN, Temel RE, Parathath S, van Gils JM, Rayner AJ, Chang AN, Suarez Y, Fernandez-Hernando C, Fisher EA, Moore KJ: Antagonism of mir-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis. J Clin Invest, 2011; 121: 2921-2931","DOI":"10.1172\/JCI57275"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Horie T, Baba O, Kuwabara Y, Chujo Y, Watanabe S, Kinoshita M, Horiguchi M, Nakamura T, Chonabayashi K, Hishizawa M, Hasegawa K, Kume N, Yokode M, Kita T, Kimura T, Ono K: Microrna-33 deficiency reduces the progression of atherosclerotic plaque in apoe(-\/-) mice. J Am Heart Assoc, 2012; 1: e003376","DOI":"10.1161\/JAHA.112.003376"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Marquart TJ, Wu J, Lusis AJ, Baldan A: Anti-mir-33 therapy does not alter the progression of atherosclerosis in low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol, 2013; 33: 455-458","DOI":"10.1161\/ATVBAHA.112.300639"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Rotllan N, Ramirez CM, Aryal B, Esau CC, Fernandez-Hernando C: Therapeutic silencing of microrna-33 inhibits the progression of atherosclerosis in ldlr-\/- mice--brief report. Arterioscler Thromb Vasc Biol, 2013; 33: 1973-1977","DOI":"10.1161\/ATVBAHA.113.301732"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Davalos A, Goedeke L, Smibert P, Ramirez CM, Warrier NP, Andreo U, Cirera-Salinas D, Rayner K, Suresh U, Pastor-Pareja JC, Esplugues E, Fisher EA, Penalva LO, Moore KJ, Suarez Y, Lai EC, Fernandez-Hernando C: Mir-33a\/b contribute to the regulation of fatty acid metabolism and insulin signaling. Proc Natl Acad Sci U S A, 2011; 108: 9232-9237","DOI":"10.1073\/pnas.1102281108"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Rayner KJ, Esau CC, Hussain FN, McDaniel AL, Marshall SM, van Gils JM, Ray TD, Sheedy FJ, Goedeke L, Liu X, Khatsenko OG, Kaimal V, Lees CJ, Fernandez-Hernando C, Fisher EA, Temel RE, Moore KJ: Inhibition of mir-33a\/b in non-human primates raises plasma hdl and lowers vldl triglycerides. Nature, 2011; 478: 404-407","DOI":"10.1038\/nature10486"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Iliopoulos D, Drosatos K, Hiyama Y, Goldberg IJ, Zannis VI: Microrna-370 controls the expression of microrna-122 and cpt1alpha and affects lipid metabolism. J Lipid Res, 2010; 51: 1513-1523","DOI":"10.1194\/jlr.M004812"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Ramirez CM, Davalos A, Goedeke L, Salerno AG, Warrier N, Cirera-Salinas D, Suarez Y, Fernandez-Hernando C: Microrna-758 regulates cholesterol efflux through posttranscriptional repression of atp-binding cassette transporter a1. Arterioscler Thromb Vasc Biol, 2011; 31: 2707-2714","DOI":"10.1161\/ATVBAHA.111.232066"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Sun D, Zhang J, Xie J, Wei W, Chen M, Zhao X: Mir-26 controls lxr-dependent cholesterol efflux by targeting abca1 and arl7. FEBS Lett, 2012; 586: 1472-1479","DOI":"10.1016\/j.febslet.2012.03.068"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Kim J, Yoon H, Ramirez CM, Lee SM, Hoe HS, Fernan dez-Hernando C: Mir-106b impairs cholesterol efflux and increases abeta levels by repressing abca1 expression. Exp Neurol, 2012; 235: 476-483","DOI":"10.1016\/j.expneurol.2011.11.010"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) de Aguiar Vallim TQ, Tarling EJ, Kim T, Civelek M, Baldan A, Esau C, Edwards PA: Microrna-144 regulates hepatic atp binding cassette transporter a1 and plasma high-density lipoprotein after activation of the nuclear receptor farnesoid x receptor. Circ Res, 2013; 112: 1602-1612","DOI":"10.1161\/CIRCRESAHA.112.300648"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Ramirez CM, Rotllan N, Vlassov AV, Davalos A, Li M, Goedeke L, Aranda JF, Cirera-Salinas D, Araldi E, Salerno A, Wanschel A, Zavadil J, Castrillo A, Kim J, Suarez Y, Fernandez-Hernando C: Control of cholesterol metabolism and plasma high-density lipoprotein levels by microrna-144. Circ Res, 2013; 112: 1592-1601","DOI":"10.1161\/CIRCRESAHA.112.300626"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Soh J, Iqbal J, Queiroz J, Fernandez-Hernando C, Hussain MM: Microrna-30c reduces hyperlipidemia and ath erosclerosis in mice by decreasing lipid synthesis and lipoprotein secretion. Nat Med, 2013; 19: 892-900","DOI":"10.1038\/nm.3200"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T18:43:48Z","timestamp":1621536228000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/21\/1\/21_20859\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":38,"URL":"https:\/\/doi.org\/10.5551\/jat.20859","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}